Y67-22830-81705
3 vaccinations
5 coded responses
23 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 447 / OH
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Registered in v-safe
-
2021-04-05
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I have had these symptoms for several days. I was better this morning but by afternoon the symptoms returnedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Fatigue or tirednessAdult check-in
- 2021-04-08
- 2021-04-16
- 2021-04-22
-
2021-04-29
Dose 2 — Pfizer-BioNTech
- 2021-04-29
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-03
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-05
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
-
2021-06-05
Survey response — day 35, dose 2MedDRA: Headache, Rash — Feeling: FairFree text: Headaches, then an unexplainable rash startedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-11
- 2021-07-31
-
2021-10-28
Survey response — 6 months, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Unusually more joint painMedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Survey response — 12 months, dose 2MedDRA: COVID-19 pneumonia, Disease complication — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Got covid pneumonia back in Jan. Still dealing with complications.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Dose 3 — Moderna
-
2022-06-21
Survey response — day 42, dose 3MedDRA: Blood pressure decreased, Cardiac disorder, Confusional state, Dizziness, Dysphonia, Dyspnoea, Hypoaesthesia, Peripheral swelling — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Complications with my heart, continued difficulty breathing, BP drops low, lightheaded and dizzy spells, very weak voice upon physical or mental exertion, numbness & swelling in hands, legs, & feet when I do anything, and mental confusion.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-21
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-06-22
-
2022-06-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech | |
| 3 | 2022-05-06 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-21 | Successful 2022-06-24 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): I have had these symptoms for several days. I was better this morning but by afternoon the symptoms returned
Release 8 — day 35, dose 2
Symptoms: Headaches, then an unexplainable rash started
Release 10 — 6 months, dose 2
Symptoms: Unusually more joint pain
Release 11 — 12 months, dose 2
Symptoms: Got covid pneumonia back in Jan. Still dealing with complications.
Release 12 — day 42, dose 3
Symptoms: Complications with my heart, continued difficulty breathing, BP drops low, lightheaded and dizzy spells, very weak voice upon physical or mental exertion, numbness & swelling in hands, legs, & feet when I do anything, and mental confusion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood pressure decreased | · | · | ✓ |
| SD | Cardiac disorder | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Confusional state | · | · | ✓ |
| SD | COVID-19 pneumonia | · | · | ✓ |
| SD | Disease complication | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release